Burzotta F, Aurigemma C, Kovacevic M, Romagnoli E, Cangemi S, Bianchini F, Nesta M, Bruno P, Trani C. Pledget-assisted hemostasis to fix residual access-site bleedings after double pre-closure technique. World J Cardiol 2022; 14(5): 297-306 [PMID: 35702322 DOI: 10.4330/wjc.v14.i5.297]
Corresponding Author of This Article
Francesco Burzotta, MD, PhD, Academic Research, Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, L.go A Gemelli 1, Rome 00168, Italy. francesco.burzotta@unicatt.it
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. May 26, 2022; 14(5): 297-306 Published online May 26, 2022. doi: 10.4330/wjc.v14.i5.297
Pledget-assisted hemostasis to fix residual access-site bleedings after double pre-closure technique
Francesco Burzotta, Cristina Aurigemma, Mila Kovacevic, Enrico Romagnoli, Stefano Cangemi, Francecso Bianchini, Marialisa Nesta, Piergiorgio Bruno, Carlo Trani
Francesco Burzotta, Cristina Aurigemma, Enrico Romagnoli, Stefano Cangemi, Francecso Bianchini, Marialisa Nesta, Piergiorgio Bruno, Carlo Trani, Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome 00168, Italy
Francesco Burzotta, Piergiorgio Bruno, Carlo Trani, Università Cattolica del Sacro Cuore, Rome 00168, Italy
Mila Kovacevic, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Mila Kovacevic, Institute of Cardiovascular Diseases of Vojvodina, Cardiology Clinic, Sremska Kamenica, Serbia
Author contributions: Burzotta F conceived the study; Burzotta F and Aurigemma C extracted, analyzed, and interpreted the data and drafted and revised the final version of the manuscript; Kovacevic M collected the clinical data and drafted and revised the final version of the manuscript; Trani C, Burzotta F, Aurigemma C, and Romagnoli E performed the procedures; Bruno P, Nesta M, Romagnoli E, Bianchini F, and Cangemi S collected the clinical data and interpreted the data; Trani C helped interpret the data and critically reviewed the manuscript for important intellectual content.
Conflict-of-interest statement: Dr. Burzotta F, Trani C and Aurigemma C received speaker’s fees from Abbott, Medtronic, and Abiomed. Other authors have no conflicts of interest.
Data sharing statement: Data are collected according to our institution center record of the activity of cath laboratory. Clinical data and procedure details were prospectively entered into a TAVI-dedicated section of an electronic database.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Francesco Burzotta, MD, PhD, Academic Research, Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, L.go A Gemelli 1, Rome 00168, Italy. francesco.burzotta@unicatt.it
Received: October 17, 2021 Peer-review started: October 17, 2021 First decision: January 25, 2022 Revised: February 6, 2022 Accepted: April 24, 2022 Article in press: April 24, 2022 Published online: May 26, 2022 Processing time: 212 Days and 16.7 Hours
Core Tip
Core Tip: This is a retrospective pilot study to report the first clinical results obtained using a novel bailout hemostasis technique for patients with double suture-based vascular closure device failure in the setting of trans-femoral transcatheter-aortic-valve-replacement. The “pledget-assisted hemostasis” technique consists of the insertion of a surgical, non-absorbable, polytetrafluoroethylene pledget over the sutures of two ProGlide (Abbott Vascular, CA, United States). The ProGlide’s knot-pushers are used to push down the pledget and the hand-made slipknot to seal the femoral artery leak. This technique was used as a bailout strategy in patients undergoing trans-femoral transcatheter aortic valve replacement with systematic double preclosure technique.
